Suchergebnisse - "Cramer, Yoninah S"

PubPharm (10)

1

Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens

enthalten in: Clinical pharmacology and therapeutics | 2022

von Tanneau, L. | Karlsson, M. | Rosenkranz, S. | +8

2

Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Tanneau, L. | Karlsson, M. | Rosenkranz, S. | +8

3

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis : a phase 2, open-label, randomised, controlled trial

enthalten in: The Lancet. Infectious diseases | 2021

von Dooley, K. | Rosenkranz, S. | Conradie, F. | +29

CommentIn: Lancet Infect Dis. 2021 Jul;21(7):894-895. - PMID 33587896

4

Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives

enthalten in: Pharmacogenetics and genomics | 2020

von Haas, D. | Cramer, Y. | Godfrey, C. | +12

5

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection : AIDS Clinical Trials Group sub-study A5334s

enthalten in: British journal of clinical pharmacology | 2020

von Venuto, C. | Cramer, Y. | Rosenkranz, S. | +6

6

Antiretroviral therapy and vaginally administered contraceptive hormones : a three-arm, pharmacokinetic study

enthalten in: The lancet. HIV | 2019

von Scarsi, K. | Cramer, Y. | Rosenkranz, S. | +31

CommentIn: Lancet HIV. 2019 Sep;6(9):e561-e563. - PMID 31371261

7

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor) : Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210

enthalten in: AIDS research and human retroviruses | 2019

von Johnson, V. | Cramer, Y. | Rosenkranz, S. | +23

8

Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis : results from ACTG A5177

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2010

von Cramer, Y. | Rosenkranz, S. | Hall, S. | +3

9

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

enthalten in: AIDS (London, England) | 2008

von Gupta, S. | Rosenkranz, S. | Cramer, Y. | +4

10

Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients

enthalten in: AIDS research and human retroviruses | 2007

von Bakshi, R. | Hamzeh, F. | Frank, I. | +6

1
[1]